Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
Min-Sun Kwak, Donghee Kim, Goh Eun Chung, Seung Joo Kang, Min Jung Park, Yoon Jun Kim, Jung-Hwan Yoon, Hyo-Suk Lee
Clin Mol Hepatol. 2012;18(4):383-390.   Published online 2012 Dec 21     DOI: https://doi.org/10.3350/cmh.2012.18.4.383
Citations to this article as recorded by Crossref logo
Bilirubin Levels Are Negatively Correlated with Adiposity in Obese Men and Women, and Its Catabolized Product, Urobilin, Is Positively Associated with Insulin Resistance
Zachary A. Kipp, Mei Xu, Evelyn A. Bates, Wang-Hsin Lee, Philip A. Kern, Terry D. Hinds
Antioxidants.2023; 12(1): 170.     CrossRef
Dietary fiber intake and non-alcoholic fatty liver disease: The mediating role of obesity
Yu Zhu, Hu Yang, Yaozong Zhang, Songxian Rao, Yufeng Mo, Honghua Zhang, Shaoxian Liang, Zhuang Zhang, Wanshui Yang
Frontiers in Public Health.2023;[Epub]     CrossRef
Bilirubin represents a negative regulator of ILC2 in allergic airway inflammation
Juan He, Guanmin Jiang, Xing Li, Qiang Xiao, Yingying Chen, Haixu Xu, Gaoyu Liu, Aihua Lei, Pan Zhou, Kun Shi, Quan Yang, Meng Zhao, Zhi Yao, Jie Zhou
Mucosal Immunology.2022; 15(2): 314.     CrossRef
Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications
John A. McClung, Lior Levy, Victor Garcia, David E. Stec, Stephen J. Peterson, Nader G. Abraham
Pharmacology & Therapeutics.2022; 231: 107975.     CrossRef
Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis
Mujdat Zeybel, Muhammad Arif, Xiangyu Li, Ozlem Altay, Hong Yang, Mengnan Shi, Murat Akyildiz, Burcin Saglam, Mehmet Gokhan Gonenli, Buket Yigit, Burge Ulukan, Dilek Ural, Saeed Shoaie, Hasan Turkez, Jens Nielsen, Cheng Zhang, Mathias Uhlén, Jan Borén, Ad
Advanced Science.2022; 9(11): 2104373.     CrossRef
Serum Bilirubin Level Is Increased in Metabolically Healthy Obesity
Jing Fu, Qiu Wang, Lin Zhang, Jia Liu, Guang Wang
Frontiers in Endocrinology.2022;[Epub]     CrossRef
Hepatoprotection of Probiotics Against Non-Alcoholic Fatty Liver Disease in vivo: A Systematic Review
Faezah Sabirin, Siong Meng Lim, Chin Fen Neoh, Kalavathy Ramasamy
Frontiers in Nutrition.2022;[Epub]     CrossRef
Assessment of efficacy and safety of two Egyptian protocols for treatment-experienced HCV patients: an observational study
Radwa Samir Hagag, Morkoss Medhat Fakhry, Ossama Ashraf Ahmed, Shaimaa Abdalaleem Abdalgeleel, Mahasen Aly Radwan, Gina Gamal Naguib
The Egyptian Journal of Internal Medicine.2022;[Epub]     CrossRef
Association of Serum Bilirubin With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Chen Liang, Zhiyuan Yu, Li Bai, Wei Hou, Shan Tang, Wei Zhang, Xinyue Chen, Zhongjie Hu, Zhongping Duan, Sujun Zheng
Frontiers in Endocrinology.2022;[Epub]     CrossRef
Elevated alpha-fetoprotein in asymptomatic adults: Clinical features, outcome, and association with body composition
Sangmi Jang, Gwang Hyeon Choi, Won Chang, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong, Nobuyuki Takahashi
PLOS ONE.2022; 17(7): e0271407.     CrossRef
Effects of vitamin E on neonatal hyperbilirubinemia in preterm newborns
Behzad Barekatain, Alireza Sadeghnia, Nahid Moradi, Maryam Yazdi
Advanced Biomedical Research.2022; 11(1): 86.     CrossRef
Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways
Olufunto O. Badmus, Sarah A. Hillhouse, Christopher D. Anderson, Terry D. Hinds, David E. Stec
Clinical Science.2022; 136(18): 1347.     CrossRef
Higher Adherence to Healthy Lifestyle Score Is Associated with Lower Odds of Non-Alcoholic Fatty Liver Disease
Yu Zhu, Hu Yang, Shaoxian Liang, Honghua Zhang, Yufeng Mo, Songxian Rao, Yaozong Zhang, Zhuang Zhang, Weiqiang Wang, Wanshui Yang
Nutrients.2022; 14(21): 4462.     CrossRef
Role of Seaweeds in Drug Induced Nephrotoxicity
Nida SOHAİL, Hafiza FARHAT
Marine Science and Technology Bulletin.2022; 11(4): 515.     CrossRef
Effect of 2 years of calorie restriction on liver biomarkers: results from the CALERIE phase 2 randomized controlled trial
James L. Dorling, Eric Ravussin, Leanne M. Redman, Manju Bhapkar, Kim M. Huffman, Susan B. Racette, Sai K. Das, John W. Apolzan, William E. Kraus, Christoph Höchsmann, Corby K. Martin
European Journal of Nutrition.2021; 60(3): 1633.     CrossRef
Bilirubin as a metabolic hormone: the physiological relevance of low levels
Justin F. Creeden, Darren M. Gordon, David E. Stec, Terry D. Hinds
American Journal of Physiology-Endocrinology and Metabolism.2021; 320(2): E191.     CrossRef
Association of Serum Bilirubin Level with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study of 1672 Obese Children
Cristina Bellarosa, Giorgio Bedogni, Annalisa Bianco, Sabrina Cicolini, Diana Caroli, Claudio Tiribelli, Alessandro Sartorio
Journal of Clinical Medicine.2021; 10(13): 2812.     CrossRef
Crosstalk Between Plasma Cytokines, Inflammation, and Liver Damage as a New Strategy to Monitoring NAFLD Progression
Tereza C. M. Fontes-Cal, Rafael T. Mattos, Nayara I. Medeiros, Bruna F. Pinto, Mayara Belchior-Bezerra, Bruna Roque-Souza, Walderez O. Dutra, Teresa C. A. Ferrari, Paula V. T. Vidigal, Luciana C. Faria, Cláudia A. Couto, Juliana A. S. Gomes
Frontiers in Immunology.2021;[Epub]     CrossRef
Is a Four-Week Ketogenic Diet an Effective Nutritional Strategy in CrossFit-Trained Female and Male Athletes?
Krzysztof Durkalec-Michalski, Paulina M. Nowaczyk, Natalia Główka, Anna Ziobrowska, Tomasz Podgórski
Nutrients.2021; 13(3): 864.     CrossRef
Oxidative Stress and Related Biomarkers in Gilbert’s Syndrome: A Secondary Analysis of Two Case-Control Studies
Karl-Heinz Wagner, Nazlisadat Seyed Khoei, Claudia Hana, Daniel Doberer, Rodrig Marculescu, Andrew Bulmer, Marlies Hörmann-Wallner, Christine Mölzer
Antioxidants.2021; 10(9): 1474.     CrossRef
Bilirubin deficiency renders mice susceptible to hepatic steatosis in the absence of insulin resistance
Weiyu Chen, Sergey Tumanov, Daniel J. Fazakerley, James Cantley, David E. James, Louise L. Dunn, Taqi Shaik, Cacang Suarna, Roland Stocker
Redox Biology.2021; 47: 102152.     CrossRef
Biliverdin reductase as a target in drug research and development: Facts and hypotheses
Cesare Mancuso
Free Radical Biology and Medicine.2021; 172: 521.     CrossRef
Association of Serum Bilirubin and Functional Variants of Heme Oxygenase 1 and Bilirubin UDP-Glucuronosyl Transferase Genes in Czech Adult Patients with Non-Alcoholic Fatty Liver Disease
Jaromír Petrtýl, Karel Dvořák, Jan Stříteský, Martin Leníček, Alena Jirásková, Václav Šmíd, Martin Haluzík, Radan Brůha, Libor Vítek
Antioxidants.2021; 10(12): 2000.     CrossRef
Circulating chemerin level is associated with metabolic, biochemical and haematological parameters—A population‐based study
Hsin‐Hua Chou, Ming‐Sheng Teng, Lung‐An Hsu, Leay‐Kiaw Er, Semon Wu, Yu‐Lin Ko
Clinical Endocrinology.2021; 94(6): 927.     CrossRef
The effects of Ramadan intermittent fasting on liver function in healthy adults: A systematic review, meta-analysis, and meta-regression
MoezAlIslam Faris, Haitham Jahrami, Dana Abdelrahim, Nicola Bragazzi, Ahmed BaHammam
Diabetes Research and Clinical Practice.2021; 178: 108951.     CrossRef
The Protective Role of the Heme Catabolic Pathway in Hepatic Disorders
Libor Vítek
Antioxidants & Redox Signaling.2021; 35(9): 734.     CrossRef
Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study
Setor K. Kunutsor, Monika Frysz, Niek Verweij, Lyanne M. Kieneker, Stephan J. L. Bakker, Robin P. F. Dullaart
European Journal of Epidemiology.2020; 35(2): 123.     CrossRef
Heme-Derived Metabolic Signals Dictate Immune Responses
Giacomo Canesin, Seyed M. Hejazi, Kenneth D. Swanson, Barbara Wegiel
Frontiers in Immunology.2020;[Epub]     CrossRef
Renal resistive index in non-alcoholic fatty liver disease as an indicator of early renal affection
Hossam El-Din A. Mahmoud, Wael A. Yousry, Shereen A. Saleh, Mohamed El Badry, Ahmed Hussein, Mostafa Hassan Ali, Hazem M. El-Hariri
Egyptian Liver Journal.2020;[Epub]     CrossRef
Plasma Krebs Cycle Intermediates in Nonalcoholic Fatty Liver Disease
Yana Sandlers, Rohan R. Shah, Ryan W. Pearce, Jaividhya Dasarathy, Arthur J. McCullough, Srinivasan Dasarathy
Journal of Clinical Medicine.2020; 9(2): 314.     CrossRef
Physiological changes in the albumin-bound non-esterified free fatty acids critically influence heme/bilirubin binding properties of the protein: A comparative, in vitro, spectroscopic study using the endogenous biomolecules
Mahtab Amoorahim, Mohammad Reza Ashrafi-Kooshk, Sajjad Esmaeili, Mohsen Shahlaei, Sajad Moradi, Reza Khodarahmi
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.2020; 235: 118298.     CrossRef
Long-term profile of serological biomarkers, hepatic inflammation, and fibrosis in a mouse model of non-alcoholic fatty liver disease
Riki Toita, Jeong-Hun Kang
Toxicology Letters.2020; 332: 1.     CrossRef
Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator–activated receptor α
Darren M. Gordon, Kari L. Neifer, Abdul-Rizaq Ali Hamoud, Charles F. Hawk, Andrea L. Nestor-Kalinoski, Scott A. Miruzzi, Michael P. Morran, Samuel O. Adeosun, Jeffrey G. Sarver, Paul W. Erhardt, Robert E. McCullumsmith, David E. Stec, Terry D. Hinds
Journal of Biological Chemistry.2020; 295(29): 9804.     CrossRef
Therapeutic application and construction of bilirubin incorporated nanoparticles
Qing Yao, Ruijie Chen, Vadivel Ganapathy, Longfa Kou
Journal of Controlled Release.2020; 328: 407.     CrossRef
Rats Genetically Selected for High Aerobic Exercise Capacity Have Elevated Plasma Bilirubin by Upregulation of Hepatic Biliverdin Reductase-A (BVRA) and Suppression of UGT1A1
Terry D. Hinds, Justin F. Creeden, Darren M. Gordon, Adam C. Spegele, Steven L. Britton, Lauren G. Koch, David E. Stec
Antioxidants.2020; 9(9): 889.     CrossRef
A Nomogram Model Based on Noninvasive Bioindicators to Predict 3-Year Risk of Nonalcoholic Fatty Liver in Nonobese Mainland Chinese: A Prospective Cohort Study
Xintian Cai, Xiayire Aierken, Ayguzal Ahmat, Yuanyuan Cao, Qing Zhu, Ting Wu, Nanfang Li, Marcello Maida
BioMed Research International.2020; 2020: 1.     CrossRef
Reduced Biliverdin Reductase-A Expression in Visceral Adipose Tissue is Associated with Adipocyte Dysfunction and NAFLD in Human Obesity
Valentina Ceccarelli, Ilaria Barchetta, Flavia Agata Cimini, Laura Bertoccini, Caterina Chiappetta, Danila Capoccia, Raffaella Carletti, Claudio Di Cristofano, Gianfranco Silecchia, Mario Fontana, Frida Leonetti, Andrea Lenzi, Marco Giorgio Baroni, Eugeni
International Journal of Molecular Sciences.2020; 21(23): 9091.     CrossRef
Natural Product Heme Oxygenase Inducers as Treatment for Nonalcoholic Fatty Liver Disease
David E. Stec, Terry D. Hinds
International Journal of Molecular Sciences.2020; 21(24): 9493.     CrossRef
Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-Hydroxybutyrate
Terry D. Hinds, Justin F. Creeden, Darren M. Gordon, Donald F. Stec, Matthew C. Donald, David E. Stec
Frontiers in Pharmacology.2020;[Epub]     CrossRef
Serum lactate levels are associated with serum alanine aminotransferase and total bilirubin levels in patients with type 2 diabetes mellitus: A cross-sectional study
Minori Ishitobi, Toshio Hosaka, Naru Morita, Ken Kondo, Toshitaka Murashima, Atsuko Kitahara, Kazuto Takahashi, Yoshikazu Sumitani, Toshiaki Tanaka, Toshihiko Yokoyama, Takuma Kondo, Hitoshi Ishida
Diabetes Research and Clinical Practice.2019; 149: 1.     CrossRef
Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity
Flavia Agata Cimini, Andrea Arena, Ilaria Barchetta, Antonella Tramutola, Valentina Ceccarelli, Chiara Lanzillotta, Mario Fontana, Laura Bertoccini, Frida Leonetti, Danila Capoccia, Gianfranco Silecchia, Claudio Di Cristofano, Caterina Chiappetta, Fabio D
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2019; 1865(6): 1490.     CrossRef
Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis
Daniela Gabbia, Marco Roverso, Maria Guido, Diana Sacchi, Michela Scaffidi, Maria Carrara, Genny Orso, Francesco Paolo Russo, Annarosa Floreani, Sara Bogialli, Sara De Martin
Nutrients.2019; 11(7): 1602.     CrossRef
CRISPR Cas9-mediated deletion of biliverdin reductase A (BVRA) in mouse liver cells induces oxidative stress and lipid accumulation
Darren M. Gordon, Samuel O. Adeosun, Somtochukwu I. Ngwudike, Christopher D. Anderson, John E. Hall, Terry D. Hinds, David E. Stec
Archives of Biochemistry and Biophysics.2019; 672: 108072.     CrossRef
Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date
Somaya Albhaisi, Arun J. Sanyal
Pharmaceutical Medicine.2019; 33(6): 451.     CrossRef
Hepatoprotective Effects of a Ruthenium(II) Schiff Base Complex in Rats with Diet-Induced Prediabetes
Lindokuhle Patience Mabuza, Mlindeli Wilkinson Gamede, Sanam Maikoo, Irvin Noel Booysen, Phikelelani Siphosethu Nguban, Andile Khathi
Current Therapeutic Research.2019; 91: 66.     CrossRef
Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemia
Ryoichi Fujiwara, Mathias Haag, Elke Schaeffeler, Anne T. Nies, Ulrich M. Zanger, Matthias Schwab
Hepatology.2018; 67(4): 1609.     CrossRef
Bilirubin in the Liver–Gut Signaling Axis
Abdul-Rizaq Hamoud, Lauren Weaver, David E. Stec, Terry D. Hinds
Trends in Endocrinology & Metabolism.2018; 29(3): 140.     CrossRef
Biliverdin reductase and bilirubin in hepatic disease
Lauren Weaver, Abdul-rizaq Hamoud, David E. Stec, Terry D. Hinds
American Journal of Physiology-Gastrointestinal and Liver Physiology.2018; 314(6): G668.     CrossRef
Bilirubin, a new therapeutic for kidney transplant?
Vikram L. Sundararaghavan, Sivjot Binepal, David E. Stec, Puneet Sindhwani, Terry D. Hinds
Transplantation Reviews.2018; 32(4): 234.     CrossRef
Loss of biliverdin reductase-A promotes lipid accumulation and lipotoxicity in mouse proximal tubule cells
Samuel O. Adeosun, Darren M. Gordon, Mary Frances Weeks, Kyle H. Moore, John E. Hall, Terry D. Hinds, David E. Stec
American Journal of Physiology-Renal Physiology.2018; 315(2): F323.     CrossRef
Genetically Regulated Bilirubin and Risk of Non-alcoholic Fatty Liver Disease: A Mendelian Randomization Study
Lei Luo, Ping An, Xinyong Jia, Xiaobian Yue, Sujun Zheng, Shuang Liu, Yu Chen, Wei An, Cheryl A. Winkler, Zhongping Duan
Frontiers in Genetics.2018;[Epub]     CrossRef
Relationship between serum bilirubin concentrations and diabetic nephropathy in Shanghai Han’s patients with type 1 diabetes mellitus
Xu Li, Lei Zhang, Haibing Chen, Kaifeng Guo, Haoyong Yu, Jian Zhou, Ming Li, Qing Li, Lianxi Li, Jun Yin, Fang Liu, Yuqian Bao, Junfeng Han, Weiping Jia
BMC Nephrology.2017;[Epub]     CrossRef
Mice with hyperbilirubinemia due to Gilbert’s syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARα
Terry D. Hinds, Peter A. Hosick, Shujuan Chen, Robert H. Tukey, Michael W. Hankins, Andrea Nestor-Kalinoski, David E. Stec
American Journal of Physiology-Endocrinology and Metabolism.2017; 312(4): E244.     CrossRef
Does bilirubin protect against developing diabetes mellitus?
Lars H. Breimer, Dimitri P. Mikhailidis
Journal of Diabetes and its Complications.2016; 30(4): 728.     CrossRef
Association between bilirubin and risk of Non-Alcoholic Fatty Liver Disease based on a prospective cohort study
Jianbo Tian, Rong Zhong, Cheng Liu, Yuhan Tang, Jing Gong, Jiang Chang, Jiao Lou, Juntao Ke, Jiaoyuan Li, Yi Zhang, Yang Yang, Ying Zhu, Yajie Gong, Yanyan Xu, Peiyi Liu, Xiao Yu, Lin Xiao, Min Du, Ling Yang, Jing Yuan, Youjie Wang, Weihong Chen, Sheng We
Scientific Reports.2016;[Epub]     CrossRef
Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor?
Terry D. Hinds, Samuel O. Adeosun, Abdulhadi A. Alamodi, David E. Stec
Medical Hypotheses.2016; 95: 54.     CrossRef
Bilirubin Binding to PPARα Inhibits Lipid Accumulation
David E. Stec, Kezia John, Christopher J. Trabbic, Amarjit Luniwal, Michael W. Hankins, Justin Baum, Terry D. Hinds, Hervé Guillou
PLOS ONE.2016; 11(4): e0153427.     CrossRef
Total Bilirubin Levels Predict Subclinical Atherosclerosis in Patients With Prediabetes
Hikmet Hamur, Hakan Duman, Levent Demirtas, Eftal Murat Bakirci, Murtaza Emre Durakoglugil, Husnu Degirmenci, Kamuran Kalkan, Erkan Yildirim, Ertan Vuruskan
Angiology.2016; 67(10): 909.     CrossRef
Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3β Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) α
Terry D. Hinds, Katherine A. Burns, Peter A. Hosick, Lucien McBeth, Andrea Nestor-Kalinoski, Heather A. Drummond, Abdulhadi A. AlAmodi, Michael W. Hankins, John P. Vanden Heuvel, David E. Stec
Journal of Biological Chemistry.2016; 291(48): 25179.     CrossRef
Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance
Min-Sun Kwak, Donghee Kim, Goh Eun Chung, Won Kim, Yoon Jun Kim, Jung-Hwan Yoon
Liver International.2015; 35(3): 944.     CrossRef
Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases
Karl-Heinz Wagner, Marlies Wallner, Christine Mölzer, Silvia Gazzin, Andrew Cameron Bulmer, Claudio Tiribelli, Libor Vitek
Clinical Science.2015; 129(1): 1.     CrossRef
Nonalcoholic Steatohepatitis Associated With Metabolic Syndrome
Kyong Yeun Jung, Sun Young Cho, Hyung Joon Kim, Suk Bae Kim, Il Han Song
Journal of Clinical Gastroenterology.2014; 48(10): 883.     CrossRef
Low serum bilirubin concentration is a novel risk factor for the development of albuminuria in patients with type 2 diabetes
Hiroshi Okada, Michiaki Fukui, Muhei Tanaka, Shinobu Matsumoto, Kanae Kobayashi, Hiroya Iwase, Kiichiro Tomiyasu, Koji Nakano, Goji Hasegawa, Naoto Nakamura
Metabolism.2014; 63(3): 409.     CrossRef
The association between indirect bilirubin levels and liver fibrosis due to chronic hepatitis C virus infection
Mustafa Cengiz, Guldal Yılmaz, Seren Ozenirler
Pathology - Research and Practice.2014; 210(8): 488.     CrossRef
Effect of Low Serum Total Bilirubin Levels (≤0.32 mg/dl) on Risk of Coronary Artery Disease in Patients With Metabolic Syndrome
Young Shin Song, Bo Kyung Koo, Nam H. Cho, Min Kyong Moon
The American Journal of Cardiology.2014; 114(11): 1695.     CrossRef
Systematic review: Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue?
Mohamed S Anwar
World Journal of Pharmacology.2014; 3(4): 209.     CrossRef
Non-alcoholic fatty liver disease: Factors associated with its presence and onset
Teruki Miyake, Teru Kumagi, Shinya Furukawa, Yoshio Tokumoto, Masashi Hirooka, Masanori Abe, Yoichi Hiasa, Bunzo Matsuura, Morikazu Onji
Journal of Gastroenterology and Hepatology.2013; 28: 71.     CrossRef